A
Anhui Anke Biotechnology
Anhui Anke Biotechnology is a biopharmaceutical high-tech enterprise based in China
At a glance
- Status
- Listed
- Founded
- 1994
- Headquarters
- Hefei, China
- Listing
- IPO 2009
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tierThoroughbred$100M+ revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- GGGood Capital Group
Series B and later1 investor entered at this stage
- ABAnhui Institute of Biology
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
234 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Anhui Anke Biotechnology was the backer or acquirer, 2017–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Anhui Anke Biotechnology's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Anhui Anke Biotechnology's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Anhui Anke Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Anhui Anke Biotechnology on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.